Goldman Sachs’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.3M Sell
1,434,135
-53,574
-4% -$1.31M ﹤0.01% 1909
2025
Q4
$33.7M Buy
1,487,709
+106,566
+8% +$2.32M ﹤0.01% 1846
2025
Q3
$27.8M Sell
1,381,143
-2,078,277
-60% -$34.8M ﹤0.01% 1929
2025
Q2
$49.4M Sell
3,459,420
-1,327,974
-28% -$15.5M 0.01% 1342
2025
Q1
$50.3M Buy
4,787,394
+2,445,872
+104% +$27.7M 0.01% 1222
2024
Q4
$28.4M Buy
2,341,522
+914,523
+64% +$12M 0.01% 1796
2024
Q3
$21M Sell
1,426,999
-1,407,728
-50% -$19.6M ﹤0.01% 2028
2024
Q2
$40.9M Buy
2,834,727
+1,711,256
+152% +$27.3M 0.01% 1313
2024
Q1
$18.3M Sell
1,123,471
-95,264
-8% -$1.49M ﹤0.01% 1919
2023
Q4
$18.2M Sell
1,218,735
-4,307,126
-78% -$48.8M ﹤0.01% 1996
2023
Q3
$62.1M Sell
5,525,861
-3,469,831
-39% -$40.3M 0.02% 983
2023
Q2
$90.5M Sell
8,995,692
-853,570
-9% -$7.92M 0.02% 760
2023
Q1
$92.6M Sell
9,849,262
-553,804
-5% -$6.53M 0.02% 730
2022
Q4
$127M Buy
10,403,066
+8,495,845
+445% +$106M 0.04% 604
2022
Q3
$23.7M Sell
1,907,221
-8,252,019
-81% -$144M 0.01% 1720
2022
Q2
$199M Sell
10,159,240
-1,945,986
-16% -$46.1M 0.06% 400
2022
Q1
$316M Buy
12,105,226
+1,541,163
+15% +$41M 0.08% 283
2021
Q4
$300M Buy
10,564,063
+1,113,073
+12% +$34.6M 0.07% 325
2021
Q3
$301M Sell
9,450,990
-495,867
-5% -$16.6M 0.08% 289
2021
Q2
$345M Buy
9,946,857
+1,210,862
+14% +$39.9M 0.09% 240
2021
Q1
$257M Buy
8,735,995
+374,058
+4% +$11.5M 0.08% 293
2020
Q4
$256M Sell
8,361,937
-3,873
-0% -$118K 0.08% 267
2020
Q3
$234M Buy
8,365,810
+1,686,764
+25% +$42.7M 0.08% 287
2020
Q2
$143M Sell
6,679,046
-388,933
-6% -$8.59M 0.05% 416
2020
Q1
$158M Buy
7,067,979
+2,185,134
+45% +$59.9M 0.06% 339
2019
Q4
$144M Sell
4,882,845
-1,162,678
-19% -$31.6M 0.04% 520
2019
Q3
$161M Buy
6,045,523
+337,212
+6% +$10.1M 0.05% 433
2019
Q2
$193M Sell
5,708,311
-776,316
-12% -$25.2M 0.06% 381
2019
Q1
$208M Buy
6,484,627
+5,314,274
+454% +$164M 0.07% 345
2018
Q4
$36.9M Buy
1,170,353
+123,295
+12% +$4.04M 0.01% 1312
2018
Q3
$36.5M Buy
+1,047,058
New +$36.8M 0.01% 1440

Other funds holding ELAN